Skip to main content
Cardiovascular Diabetology logoLink to Cardiovascular Diabetology
. 2025 Dec 28;25:30. doi: 10.1186/s12933-025-03048-1

The effect of exercise characteristics on HbA1c and other cardiovascular risk factors in adults with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials

Matthijs Michielsen 1,2,, Jan Yagiz 1, Matthijs Hanssens 1, Jomme Claes 1, Lieze Geuns 1, Tin Gojevic 5,6, Dominique Hansen 5,6, Guido Claessen 3,4,7, Marieke De Craemer 2, Véronique Cornelissen 1
PMCID: PMC12859889  PMID: 41457265

Abstract

Background

Exercise is a first-line therapy in adults with type 2 diabetes, yet its optimal characteristics remain unclear. Moreover, most meta-analyses focus on glycated haemoglobin (HbA1c), providing limited insight into the concomitant effects of these exercise programmes on the overall cardiovascular risk profile.

Methods

A systematic review and meta-analysis was conducted. Nine electronic databases were searched from inception to January 2025 for randomised controlled trials evaluating the effects of exercise on HbA1c and concomitantly reported cardiovascular risk factors in adults with type 2 diabetes. Outcomes were pooled using random-effects models and analysed by exercise type. Subgroup analyses were performed to explore optimal exercise characteristics for improving HbA1c.

Results

One hundred randomised controlled trials (7195 participants, 136 interventions) were included. All exercise types significantly improved HbA1c, with the largest reductions observed for combined training (− 0.74%, 95% CI [− 0.91; − 0.57], n = 38) and high-intensity interval training (HIIT) (− 0.71%, 95% CI [− 1.07; − 0.35], n = 13), followed by continuous aerobic training (CAT) (− .62%, 95% CI [− 0.84; − 0.41], n = 57) and resistance training (− 0.36%, 95% CI [− 0.51; − 0.20], n = 38). Supervised interventions and those prescribing a weekly volume of 150–210 min were consistently the most effective. Analyses of concomitantly reported cardiovascular risk factors showed improvements in VO2peak with CAT, combined training and HIIT (+ 2.77 to + 4.19 ml/kg/min) and in muscle strength with resistance and combined training (SMD: + 0.44 to + 0.66). All modalities reduced fasting plasma glucose (− 0.60 to − 1.13 mmol/L), LDL cholesterol (− 0.18 to − 0.31 mmol/L) and systolic blood pressure (− 1.24 to − 4.15 mmHg), while improvements in body fat were observed only after CAT, combined training and HIIT (SMD: − 0.36 to − 0.59).

Conclusions

All types of exercise significantly improved HbA1c, with combined training producing the largest reduction. Moreover, each modality provides distinct advantages for other cardiovascular risk factors, with combined training offering the broadest benefits and HIIT serving as a time-efficient alternative. Tailoring exercise programmes based on the patient’s individual risk profile, and adjusting exercise types accordingly, may help optimise outcomes.

Trial registration

PROSPERO (CRD42025642391).

Graphical abstract

graphic file with name 12933_2025_3048_Figa_HTML.jpg

Supplementary Information

The online version contains supplementary material available at 10.1186/s12933-025-03048-1.

Keywords: Exercise, Continuous aerobic training, Resistance training, Combined training, High-intensity interval training, HbA1c, Cardiovascular risk profile, Type 2 diabetes, Meta-analysis

Research insights

What is currently known about this topic?

  • Exercise is first-line therapy in adults with T2D and lowers HbA1c.

What is the key research question?

  • Which exercise types and characteristics improve HbA1c and cardiovascular risk the most in adults with T2D?

What is new?

  • Identification of optimal training mode and characteristics to reduce HbA1c

  • Insights into exercise mode-specific cardiovascular risk reduction

How might this study influence clinical practice

  • Tailoring exercise to individual risk profiles may improve cardiovascular outcomes in T2D.

Background

Diabetes is a rapidly growing public health concern, projected to affect 853 million individuals by 2050, constituting 13% of the global adult population [1]. Approximately 90% of adults with diabetes have type 2 diabetes, a disease frequently accompanied by obesity, hypertension, and hyperlipidaemia, which significantly increase the risk of premature cardiovascular morbidity and mortality [2, 3].

Epidemiological studies consistently show that higher levels of physical activity reduce the incidence of type 2 diabetes and result in better health outcomes in those already diagnosed [4, 5]. Accordingly, structured, planned and repetitive physical activity, hereafter referred to as exercise, is recommended in all guidelines as a key intervention (class IA recommendation) for the management of adults with type 2 diabetes [6, 7].

Continuous aerobic training (CAT) is the most extensively studied exercise modality and has consistently been shown to reduce glycated haemoglobin (HbA1c), a key marker of long-term glycaemic control and diabetes-related morbidity [810]. Meta-analyses report mean reductions of up to 0.50% [8, 11]. However, in recent years resistance training has also emerged as an effective intervention to lower HbA1c, with mean reductions of up to 0.39% [12]. Combining continuous aerobic and resistance training appears additive as demonstrated in a recent meta-analysis by Liang et al. who reported additional HbA1c reductions of 0.12% and 0.25% compared with continuous aerobic or resistance training alone, respectively [8]. Moreover, over the past decade high-intensity interval training (HIIT) has gained attention as a time-efficient and potent training method, with meta-analyses indicating greater HbA1c reduction than CAT [8, 13].

Despite these clinically meaningful improvements in glycaemic control, most existing meta-analyses in populations with type 2 diabetes have focused almost exclusively on HbA1c [8, 9, 14], overlooking the broader cardiovascular risk profile [2, 15]. Furthermore, although research on dose-response relationships has expanded in recent years, significant knowledge gaps persist regarding the optimal FITT (Frequency, Intensity, Type, and Time) parameters [16] for exercise prescription in this population [8, 9]. Clearer evidence on the efficacy of different exercise parameters is essential for maximising both metabolic and cardiovascular benefits.

Therefore, the primary objective of the current meta-analysis is to summarise and compare the effects of continuous aerobic, resistance, combined and high-intensity interval training on HbA1c in adults with type 2 diabetes, and to examine the effect of different exercise characteristics. Secondary outcomes included the effects of these exercise modalities on the concomitantly reported cardiovascular risk factors. The findings are intended to support clinicians in selecting the most appropriate exercise programme for an adult with type 2 diabetes and one or more other cardiovascular risk factors.

Methods

This systematic review and meta-analysis was prospectively registered in PROSPERO (CRD42025642391) and conducted in collaboration with KU Leuven Libraries—2Bergen, Learning Centre Désiré Collen (Leuven, Belgium). Reporting followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [17] guidelines.

Search strategy, selection and eligibility criteria

A comprehensive literature search was performed in nine electronic databases (MEDLINE (PubMed), Embase, Web of Science, Scopus, CENTRAL, CINAHL, SPORTDiscus, PEDro, clinicaltrials.gov) from inception to January 10th, 2025. Reference lists of relevant recent systematic reviews and meta-analyses were also hand-searched for additional studies. The detailed search strategies for each database are provided in the supplementary file, pages 2–20.

After removal of duplicates in EndNote 21 software (Clarivate, Philadelphia, USA), the remaining articles were uploaded to Rayyan (Rayyan Systems, Cambridge, MA, USA) for screening. Titles and abstracts were independently assessed for eligibility by two pairs of reviewers (JY, MH, MM, LG) [18]. Full texts of potentially eligible studies were then screened by two independent reviewers (JG and MH) with reasons for exclusion documented. Discrepancies were resolved by consensus with a third reviewer (MM).

Eligibility criteria for inclusion in the meta-analysis were as follows:

  • (i)

    Randomised controlled trials (RCT), published in English, in a peer-reviewed journal.

  • (ii)

    Adults (≥ 18 years) with type 2 diabetes, without established cardiovascular, pulmonary, neurological, oncological or any unstable chronic diseases.

  • (iii)

    Investigating the impact of CAT, resistance, combined or HIIT training, with a minimum duration of 4 weeks. CAT was defined as walking, cycling, jogging, swimming, or other dynamic activities to improve fitness and performed at a constant work rate. Resistance training could include machines and free-weights, own body weight, resistance bands or other activities aimed to improve muscle strength. Combined training was defined as the integration of both aerobic and resistance exercises. HIIT was defined as any exercise session including repeated high-intensity exercise bouts alternated with recovery periods (i.e., including sprint interval training (SIT)). Comparator groups were eligible if they did not receive any exercise and differed from the intervention groups solely in exposure to exercise.

  • (iv)

    Reporting on changes in HbA1c.

Outcomes

The primary outcome was change in HbA1c from baseline to the first follow-up after completion of the exercise intervention. Secondary outcomes included changes in cardiovascular risk factors such as body composition (Body Mass Index (BMI), body weight, body fat, waist circumference), blood pressure, fasting plasma glucose (FPG), total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL) and triglycerides, as well as health-related physical fitness components (peak oxygen uptake (VO2peak) and muscle strength) and physical activity. Outcomes were included in the analyses if reported in at least three trials.

Data extraction

Two pairs of reviewers (JY, MH, MM, LG) independently extracted data using a standardised data extraction sheet (Microsoft Excel, Redmond, WA, USA). Extracted variables included: study characteristics (author information, publication year, country of origin, study design, type of analysis and drop-out rate), details of the exercise intervention (type, frequency, intensity, duration, level of supervision and adherence) and control group (content and level of supervision) participant characteristics (sex, age, duration of diabetes, medication intake and smoking status), primary (HbA1c) and secondary (other clinical cardiovascular risk factors) outcomes, reported as either mean or mean difference (MD) and standard deviations (SD) or standard errors of means. Data reported in conventional units were converted to standard units after data extraction.

Quality assessment

Risk of bias and methodological quality of eligible studies were assessed using the Tool for the assESsment of study quality and reporting in EXercise (TESTEX) by two reviewers (JY and MH) and discrepancies were resolved by consensus with a third reviewer (MM) [19]. The TESTEX scale is a validated 15-point (12-item) instrument specifically designed to evaluate the quality and reporting of exercise training studies [19]. The strength of this tool lies in the incorporation of domains that are relevant to exercise training studies that are not captured by other Risk of Bias tools.

Statistical analysis

Baseline characteristics were described using mean values, calculated by combining mean baseline data from the training group and the control group, weighted by the number of participants in each group.

Comprehensive Meta-Analysis V4, (Biostat Inc, NJ, USA) was used for all meta-analyses. The effect sizes were calculated either from the pre and post mean ± SD of the intervention and control groups or from the mean change ± SD within each group. When SD was not reported, this was derived from standard errors or confidence intervals [20]. For analyses based on change scores, a conservative pre–post correlation coefficient of 0.5 was used [20]. Each effect size was then weighted by the inverse of its variance. In trials with multiple intervention arms sharing one control group, the control group was proportionally split into smaller subgroups [20].

Pooled outcomes were estimated using random-effects models to account for heterogeneity [20, 21]. Effect sizes were expressed as mean differences (MD), or standardized mean differences (SMD) when units differed. Analyses were stratified by exercise type with additional subgrouping for the primary outcome by exercise sub-type. Between-group differences were tested using Cochran’s Q. Subgroup analyses further examined the influence of training characteristics on the primary outcome across all exercise types. For the exercise intensity, classification was made based on ACSM guidelines [22].

Statistical heterogeneity was evaluated with Cochran’s Q (p < 0.05) and the I2 statistic (> 50% indicating substantial heterogeneity) [23]. To complement measures of heterogeneity, prediction intervals were added to quantify the expected range of true effects in future studies, providing a clinically interpretable estimate of between-study variability [24]. A leave-one-out sensitivity analysis, removing each study in turn to assess the stability of the pooled effect and any change in significance, was performed for the primary outcome for all exercise types. Publication bias was examined through visual inspection of the funnel plots, Egger’s regression test (p < 0.10) [25] and the trim-and-fill method [26].

Results

Study selection and characteristics

A PRISMA flow diagram of the literature search and selection is presented in Fig. 1.

Fig. 1.

Fig. 1

PRISMA flowchart of the study inclusion. RCT randomised controlled trial; *established cardiovascular, pulmonary, neurological, oncological or other unstable chronic diseases (n = 11), not conducted in individuals with type 2 diabetes (n = 4), not conducted in adults (n = 1); **combined intervention (n = 4), behaviour change intervention (n = 2), control group receiving an active intervention (n = 3)

The initial search identified a total of 11,559 articles. Following deduplication and title/abstract screening, 206 articles remained for full-text review. Of these, 100 RCTs comprising 136 distinct interventions were included.

Study characteristics

The included studies were published between 1986 and 2024 and were conducted in 33 different countries. Most studies were conducted in high-income (n = 49) and upper-middle-income (n = 37) countries, with fewer from lower-middle-income (n = 13) and low-income (n = 1) countries. Exercise intervention duration ranged from 4 to 52 weeks. CAT was the most frequently studied exercise intervention (n = 57, 42%), followed by combined training (n = 38, 28%), resistance training (n = 28, 21%) and HIIT (n = 13, 10%). Among the HIIT interventions, only one study used a SIT protocol. The mean training frequency was 3.5 sessions per week (range: 1–7), with a mean duration of 49 min per session (range: 7.5–120). Resistance training intensity was assessed using 1 repetition maximum (1RM) in 48% of the interventions (n = 32) and averaged 68% of 1RM (range: 40–85). For CAT, combined and HIIT interventions, intensity was mostly prescribed as a percentage of VO2peak (n = 30, 28%), heart rate peak (n = 35, 32%), heart rate reserve (n = 13, 12%) or Borg scale (n = 9, 8%). Most interventions were fully supervised (n = 100, 74%) or partially supervised (n = 22, 16%). Mean adherence across studies was 90% (range 60–100) with a mean dropout rate of 12% (range 0–37). A detailed summary of the data extracted from each study is presented in supplementary file, pages 21–32.

Study quality

Details of the TESTEX risk of bias assessment are provided in the supplementary file, pages 33–37. The median score for study quality was 3 out of 5 (range 1–5). Eligibility criteria were reported in 92% of studies, representing the highest-scoring item, whereas blinding of the assessor was the lowest, reported in only 30% of studies. For quality of study reporting, the median score was 6 out of 10 (range 3–10), with 61% of studies reporting a study withdrawal rate below 15%. Only 10% of studies included physical activity monitoring in the control groups.

Patient characteristics

A total of 7195 participants (47% male) were analysed. The mean age of participants was 57.1 years (range: 37.0–71.2), and the time since diagnosis of diabetes was 8.3 years (range: 1.5–21.1). The mean BMI was 29.7 kg/m2 (range: 22.7–39.7), and the mean baseline HbA1c level was 7.7% (range: 5.9–10.5). Among interventions reporting medication intake (n = 56, 41%), 86% of participants used hypoglycaemic medication, and 9% received insulin therapy. Among those reporting smoking status (n = 46, 34%), 9% of participants were current smokers. An overview of the aggregated mode-specific baseline age, HbA1c and BMI is provided in supplementary Table 2, page 32. No systematic differences were present between the different exercise modalities.

Outcomes

HbA1c

All four exercise types significantly reduced HbA1c with mean changes ranging between − 0.36% (95% CI [− 0.51; − 0.20], n = 28) following resistance training and − 0.74% (95% CI [− 0.91; − 0.57], n = 38) following combined training (Fig. 2). These pooled effects were characterised by substantial between-study heterogeneity (I2 > 50%, Cochrane Q, p < 0.05). Across exercise types, resistance training was less effective than combined training (p < 0.001), CAT (p = 0.05) and HIIT (p = 0.08). No significant differences were observed among the different CAT modalities: walking (MD: − 0.51%, 95% CI [− 0.73; − 0.30], n = 28), running (MD: − 0.54%, 95% CI [− 0.91; − 0.16], n = 6), cycling (MD: − 0.54%, 95% CI [− 1.07; − 0.02], n = 7) and combining different CAT modes (MD: − 0.82%, 95% CI [− 1.46; − 0.19], n = 9). For resistance training, a significant reduction was observed when using machines and free weights (MD: − 0.35%; 95% CI [− 0.52; − 0.18], n = 21), whereas programmes using resistance bands did not result in a significant improvement (MD: − 0.19%, 95% CI [− 1.24; 0.87], n = 2). Among HIIT interventions, running-based protocols (MD: − 1.20%, 95% CI [− 1.51; − 0.89], n = 4) yielded significantly greater (p < 0.001) reductions in HbA1c, than cycling-based programmes (MD: − 0.38%, 95% CI [− 0.65; − 0.12], n = 9).

Fig. 2.

Fig. 2

Forest plot including the mean difference, confidence intervals (thick lines) and prediction intervals (thin lines) on HbA1c, for both the primary and secondary exercise mode

Table 1 summarises subgroup analyses according to the FITT principles and the level of supervision for each of the main exercise types. Overall, supervised programmes consistently produced greater effect sizes, although differences from unsupervised programmes were not statistically significant. However, for resistance training and HIIT significant reductions in HbA1c were observed only in supervised interventions. Regarding frequency, 3 sessions per week yielded the strongest reductions in HbA1c in all exercise types. Lower frequencies remained effective for combined training, whereas higher frequencies did not further increase changes in HbA1c. Moderate and high intensity training significantly reduced HbA1c in CAT and resistance training, whereas low intensity did not. Session durations > 45 min were most effective in resistance and combined training, whereas CAT benefited slightly more from shorter sessions (≤ 45 min). Across exercise types, weekly volumes of 150–210 min were optimal, with no additional benefit at > 210 min. Intervention duration did not affect statistical significance of outcomes; both shorter (≤ 16 weeks) and longer (> 16 weeks) interventions were effective, with slightly larger effect sizes in shorter programmes.

Table 1.

Subgroup analyses for the effect of different exercise modalities on HbA1c using a random-effects model

CAT Resistance training Combined training HIIT
N MD [95 CI] P N MD [95 CI] P N MD [95 CI] P N MD [95 CI] P
Supervision
Yes 37 − 0.69 [− 0.97; − 0.42] < 0.001 23 − 0.39 [− 0.55; − 0.22] < 0.001 28 − 0.77 [− 1.01; − 0.54] < 0.001 12 − 0.73 [− 1.12; − 0.34] < 0.001
No 19 − 0.46 [− 0.73; − 0.18] 0.001 5 − 0.16 [− 0.60; 0.29] 0.481 10 − 0.73 [− 0.91; − 0.55] < 0.001 1 − 0.50 [− 1.17; 0.17] 0.141
Frequency (x/week)
< 3 2 − 0.48 [− 1.12; 0.16] 0.140 6 − 0.24 [− 0.48; − 0.00] 0.053 4 − 0.26 [− 0.43; − 0.10] 0.002
3 34 − 0.73 [− 1.01; − 0.46] < 0.001 21 − 0.42 [− 0.61; − 0.24] < 0.001 24 − 0.78 [− 1.05; − 0.51] < 0.001 12 − 0.74 [− 1.14; − 0.34] < 0.001
> 3 21 − 0.44 [− 0.72; − 0.17] 0.002 1 − 0.40 [− 0.28; 1.08] 0.247 10 − 0.79 [− 0.92; − 0.66] < 0.001 1 − 0.42 [− 0.84:− 0.00] 0.050
Intensity
Low 2 − 1.49 [− 2.92; 0.02] 0.053 1 − 0.47 [− 1.39; 0.45] 0.32
Moderate 22 − 0.55 [− 0.90; − 0.19] 0.003 4 − 0.65 [− 0.85; − 0.45] < 0.001
High 19 − 0.55 [− 0.87; − 0.22] 0.001 9 − 0.55 [− 0.88; − 0.22] 0.001 13 − 0.71 [− 1.07; − 0.35] < 0.001
Session duration (min)
≤ 30 8 − 0.67 [− 0.97; − 0.37] < 0.001 1 − 0.01 [− 0.31; 0.29] 0.947 4 − 0.49 [− 0.88; − 0.09] 0.016 8 − 0.49 [− 0.84; − 0.14] 0.006
31–45 17 − 0.62 [− 0.89; − 0.35] < 0.001 5 − 0.33 [− 0.80; 0.13] 0.160 5 − 0.41 [− 0.99; 0.16] 0.156 4 − 0.90 [− 1.61; − 0.19] 0.013
> 45 30 − 0.57 [− 0.90; − 0.24] 0.001 13 − 0.48 [− 0.64; − 0.31] < 0.001 26 − 0.80 [− 1.00; − 0.59] < 0.001 1 − 1.84 [− 2.83; − 0.85] < 0.001
Weekly exercise (min/week)
< 150 17 − 0.64 [− 0.90; − 0.39] < 0.001 8 − 0.34 [− 0.61; − 0.08] 0.011 9 − 0.44 [− 0.68; − 0.21] < 0.001 11 − 0.66 [− 1.07; − 0.26] 0.001
150–210 28 − 0.71 [− 1.03; − 0.40] < 0.001 11 − 0.48 [− 0.68; − 0.27] < 0.001 17 − 0.88 [− 1.21; − 0.55] < 0.001 1 − 1.84 [− 2.83; − 0.85] < 0.001
> 210 9 − 0.14 [− 0.57; 0.30] 0.545 8 − 0.85 [− 1.02; − 0.68] < 0.001
Intervention duration (weeks)
≤ 16 44 − 0.63 [− 0.86; − 0.39] < 0.001 18 − 0.41 [− 0.58; − 0.23] < 0.001 23 − 0.80 [− 1.06; − 0.54] < 0.001 13 − 0.71 [− 1.07; − 0.35] < 0.001
> 16 13 − 0.60 [− 1.02; − 0.19] 0.004 10 − 0.33 [− 0.58; − 0.08] 0.011 15 − 0.68 [− 0.91; − 0.45] < 0.001

Exploratory meta-regression analyses indicated that greater reductions in BMI and body fat, as well as higher baseline HbA1c levels and younger age were associated with larger reductions in HbA1c across all studies.

Pooled subgroup analyses across all exercise types, full measures of heterogeneity, a sensitivity analyses restricted to supervised interventions, and all exploratory meta-regression analyses are provided in supplementary file, pages 38–49.

Other cardiovascular risk factors

Figure 3 presents the pooled effect sizes for concomitantly reported cardiovascular risk factors across exercise types. Full analyses, including heterogeneity assessments and between-type comparisons are provided in the supplementary file, page 49–52.

Fig. 3.

Fig. 3

The subgroup analyses for the effect of different exercise modes on other concomitant reported cardiovascular risk factors.*: standardized mean difference; green: significant; yellow: insignificant; grey: not studied

Physical fitness

VO2peak improved significantly following CAT (MD: + 2.77 ml/kg/min, 95% CI [1.98; 3.56], n = 28), combined training (MD: + 2.68 ml/kg/min, 95% CI [1.66; 3.70], n = 17) and HIIT (MD: +4 .19 ml/kg/min, 95% CI [2.59; 5.79], n = 5), but did not change after resistance training. Muscle strength increased following resistance training (SMD: 0.44, 95% CI [0.23; 0.64], n = 7) and combined training (SMD: 0.66, 95% CI [0.39; 0.94], n = 12) with no change after CAT or HIIT.

Blood biochemistry

All four types of exercise reduced FPG with mean changes ranging between − 0.60 mmol/L (95% CI [− 1.60; − 0.03], n = 19) after resistance training and − 1.13 mmol/L (95% CI [− 1.45; − 0.81], n = 39) after CAT. LDL decreased significantly following all four exercise types with mean differences ranging between − 0.19 mmol/L (95% CI [− 0.27; − 0.11], n = 32) for CAT and − 0.31 (95% CI [− 0.48; − 0.15], n = 24) for combined training. HDL only significantly improved following CAT (MD: 0.05 mmol/L, 95% CI [-0.01; 0.09], n = 35) and combined training (MD: 0.09, 95% CI [0.06; 0.11], n = 26). Total cholesterol was significantly reduced following all exercise types except for resistance training, with mean changes ranging between − 0.26 mmol/L (95% CI [− 0.39; − 0.14], n = 23) for combined training and − 0.42 mmol/L (95% CI [− 0.61; − 0.23], n = 10) for HIIT. Triglycerides only decreased significantly after resistance (MD: − 0.18 mmol/L, 95% CI [− 0.23; − 0.13], n = 19) and combined training (MD: − 0.20 mmol/L, 95% CI [− 0.28; − 0.11], n = 24).

Blood pressure

All four types of exercise produced significant reductions in SBP and DBP, except for DBP following HIIT. Mean differences for SBP ranged between − 4.15 mmHg (95% CI [− 8.09; − 0.22], n = 15) following resistance training and − 1.14 mmHg (95% CI [− 2.41; − 0.07], n = 28) following CAT. For DBP, mean differences ranged between − 3.03 mmHg (95% CI [− 4.96; − 1.10], n = 15) following resistance training and − 0.17 mmHg (95% CI [− 2.98; 2.64], n = 8) following HIIT. No significant differences were observed between exercise types.

Anthropometrics

All four types of exercise decreased body fat, except for resistance training. The largest reduction in BMI was observed following HIIT (MD: − 0.47 kg/m2, 95% CI [− 0.84; − 0.11], n = 9), whereas the most substantial body fat reduction occurred following combined training (SMD: − 0.59, 95% CI [− 0.92; − 0.27], n = 17) and CAT (SMD: − 0.54, 95% CI [− 0.86; − 0.21], n = 25). Waist circumference significantly decreased following all exercise types, with mean changes ranging from − 1.79 cm (95% CI [− 2.89; − 0.69], n = 14) following CAT to − 5.89 cm (95% CI [− 9.02; − 2.75], n = 4) following HIIT.

Physical activity

Changes in habitual physical activity outside of the exercise programmes were assessed in 10 interventions (CAT: n = 3, resistance training: n = 3, combined training: n = 4). Physical activity was measured using questionnaires (n = 8), an accelerometer (n = 1), or a diary converted to MET-hours (n = 1). A significant increase in physical activity was only observed after CAT (SMD: 1.00, 95% CI [0.11; 1.89], n = 3).

Publication bias and sensitivity analyses

A sensitivity analysis of the primary outcome (HbA1c) was conducted using a leave-one-out approach, which did not influence the effect size for any type of exercise. However, visual inspection of the individual funnel plots and Egger’s regression test (supplementary file, pages 38–42) suggested a publication bias for CAT (intercept = 1.65, p = 0.003), combined training (intercept = − 1.01, p = 0.047) and HIIT (intercept = − 1.98, p = 0.01).

Duval and Tweedie trim-and-fill method was used to estimate the number of potentially missing studies due to bias. For CAT, 13 missing studies were imputed on the left side of the funnel plot, adjusting the effect size from − 0.62 [− 0.84; − 0.41] to − 0.85 [− 1.05; − 0.65]. Similarly for HIIT, imputing one study shifted the effect from − 0.71 [− 1.07; − 0.35] to − 0.75 [− 1.11; − 0.40]. For resistance training 6 missing studies were imputed on the right side of the funnel plot, adjusting the effect size from − 0.36 [− 0.51; − 0.20] to − 0.27 [− 0.44; − 0.11]. No missing studies were identified for combined training.

Discussion

Principal findings

This systematic review and meta-analysis, including 100 RCTs with 7195 participants, evaluated the impact of CAT, resistance, combined, and HIIT on HbA1c and concomitantly reported cardiovascular risk factors in adults with type 2 diabetes. All exercise types significantly reduced HbA1c with combined training showing the greatest benefit, followed by HIIT, CAT and resistance training. Across exercise types, supervised interventions proved more effective than unsupervised programmes. Beyond glycaemic control, all exercise modalities improved several distinct cardiovascular risk factors, underscoring the importance of tailoring exercise therapy to the individual patient.

Optimal exercise programme characteristics for improving HbA1c

Irrespective of the type of exercise, supervised programmes consistently yielded larger effect sizes compared to unsupervised programmes, a finding consistent with previous research and current exercise guidelines [11, 27]. Supervision may support correct exercise execution and progression, while unsupervised training may be limited by lower adherence and compliance to intensity [27].

All four exercise types produced clinically meaningful improvements in HbA1c ranging between − 0.74 and − 0.36%. Among these, programmes combining CAT with resistance training resulted in the largest reduction in HbA1c. These findings align with prior literature [8, 28, 29] and may be explained by the additive effects of enhanced mitochondrial oxidative capacity from CAT and improved skeletal muscle glucose storage from resistance training [30]. For CAT, no differences were observed between walking, running or cycling interventions. Resistance training was effective when machines and free weights were used, but not with resistance bands. However, the latter were evaluated in only two studies, both unsupervised or partially supervised, and one at low intensity, warranting cautious interpretation and further study. Moreover, the smaller HbA1c reductions observed in resistance training may partly reflect the lower reductions in body fat achieved with this modality, which is a known mediator of improvements in glycaemic control [31, 32].

A training frequency of three sessions per week appeared optimal in reducing HbA1c, as higher frequencies did not show additional benefits. One possible explanation is that the effect of exercise on insulin sensitivity lasts for up to 72 h, which could have limited the added value of more frequent sessions on glycaemic control [33, 34].

Moderate-intensity programmes totaling 150–210 min per week were most effective for both CAT and resistance training, with neither higher intensity nor greater volume providing additional benefits. These findings are consistent with earlier meta-analyses reporting flattened dose-responses beyond 210–240 min/week for CAT and 170 min/week for resistance training [8, 9]. Importantly, when CAT and resistance modalities were combined, an equal training dose (150–210 min/week) resulted in amplified HbA1c reductions, supporting the presence of an additive interaction. Notably, shorter training sessions appeared sufficient for CAT, whereas resistance training required a longer session duration (> 45 min) to elicit optimal HbA1c reductions.

HIIT offered reductions in HbA1c comparable to combined training, while demanding lower total training volume, making it a promising time-efficient alternative. Running-based HIIT protocols appeared more effective than cycling-based ones, potentially reflecting greater muscle recruitment and energy expenditure [35]. However, the small number of trials and substantial similarity in exercise protocols preclude definitive conclusions regarding optimal FITT characteristics. Still, our findings align with previous dose-response analyses showing no plateau for HIIT, suggesting that individuals capable and willing to sustain higher training volumes might achieve even greater HbA1c reductions [8]. Yet, as nearly all HIIT interventions were supervised and short in duration, uncertainties remain regarding long-term feasibility, adherence, and effectiveness in unsupervised or home-based contexts.

Overall trial duration did not appear to influence the effect of exercise on HbA1c, with the largest effect sizes observed in the shortest interventions. As changes in HbA1c require at least two to three months to become fully apparent, these findings likely reflect a decline in adherence in longer interventions, rather than an accelerated physiological response in the shorter interventions [14, 36, 37]. This emphasises the need for strategies that promote long-term adherence, such as hybrid or tele-monitored interventions, preferably combined with structured exercise counseling [38].

The benefits of exercise on the broader cardiovascular risk profile

Beyond HbA1c, concomitantly reported cardiovascular risk factors were assessed as secondary outcomes. CAT and combined training both improved VO2peak beyond the minimal clinically important difference of 1 mL/kg/min. However, the most profound increase was seen following HIIT, where increases exceeded 1 metabolic equivalent (3.5 mL/kg/min), a threshold associated with a 16% reduction in all-cause mortality risk [39]. Resistance training alone did not improve VO₂peak, yet it was, together with combined training, the only modality to significantly increase muscular strength. Since reduced strength is associated not only with the prevalence of type 2 diabetes but also with greater morbidity and mortality among affected individuals [40, 41], interventions integrating both CAT and resistance components appear to provide the most comprehensive cardiovascular protection. Similarly, while CAT produced the most pronounced improvements in anthropometric measures and resistance training demonstrated more profound effects on blood pressure, combined training merged these benefits, resulting in the most favorable overall cardiovascular risk reduction.

HIIT emerged as a valid and time-efficient alternative, offering broad cardiovascular benefits and showing particular promise if weight loss is prioritised. Nonetheless, most HIIT interventions were short-term and supervised, warranting caution in extrapolating these findings to long-term or unsupervised practice.

Notably, physical activity was only measured in just 10 interventions and showed significant increases only after CAT. This scarcity of data highlights an important gap in the literature, as sustained increases in habitual physical activity could consolidate or extend the benefits of structured exercise. Future studies should therefore not only focus on optimising exercise prescription, but also on strategies that facilitate the translation of structured exercise into lasting lifestyle changes.

Strengths and limitations

This meta-analysis has several strengths. First, the comprehensive and well-structured search strategy led to the inclusion of a larger number of studies compared to previous reviews, increasing statistical power. Second, we assessed both optimal subtypes and training modalities within each exercise type, refining clinical exercise prescriptions. Third, where possible, we reported mean differences to facilitate clinical interpretation of the results. Lastly, by evaluating not only HbA1c but also a range of concomitantly reported cardiovascular risk factors, this study provides a more holistic view of the cardiovascular benefits of exercise in adults with type 2 diabetes.

Nonetheless, several limitations should be considered. As we aimed to investigate the impact of exercise interventions on concomitantly reported cardiovascular risk factors, outcomes were restricted to those reported in included studies. Additionally, as medication adjustments during interventions are common, they may have confounded observed effect sizes [42, 43]. Future individual participant data meta-analyses are needed to better account for these influences.

Moreover, there was considerable heterogeneity between studies and the presence of publication bias in combination with the relatively low quality of the included studies suggests that caution is warranted when interpreting the magnitude of effects.

Conclusions

All exercise modalities significantly reduced HbA1c, highlighting the role of exercise as a core component in the management of type 2 diabetes. Combining CAT and resistance training offers the most comprehensive metabolic and cardiovascular benefits. Based on the included studies, an exercise volume of 150–210 min of moderate intensity per week, distributed over three sessions, appeared most effective. The superiority of supervised over unsupervised interventions further underscores the value of guided or hybrid programmes. HIIT may be considered a valid and time-efficient alternative to combined training, especially in individuals prioritising improvements in cardiorespiratory fitness and weight loss. However, its feasibility should be assessed in long-term and unsupervised or home-based contexts. Finally, tailoring the emphasis of an exercise program based on the patient’s metabolic profile, and adjusting FITT parameters accordingly, may help create individualised regimens that yield the greatest benefits for specific patient subgroups.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1 (4.1MB, docx)

Acknowledgements

Not applicable.

Abbreviations

HbA1c

Glycated haemoglobin

CAT

Continuous aerobic training

HIIT

High-intensity interval training

SIT

Sprint interval training

FITT

Frequency, intensity, type, and time

BMI

Body mass index

FPG

Fasting plasma glucose

LDL

Low-density lipoprotein

HDL

High-density lipoprotein

VO2peak

Peak oxygen uptake

SBP

Systolic Blood pressure

DBP

Diastolic blood pressure

1RM

One repetition maximum

RCT

Randomised controlled trial

MD

Mean difference

SMD

Standardized mean difference

CI

Confidence interval

SD

Standard deviation

ACSM

American College of Sports Medicine

PRISMA

Preferred reporting items for systematic reviews and meta-analyses

PROSPERO

International prospective register of systematic reviews

TESTEX

Tool for the assessment of study quality and reporting in exercise

MEDLINE

Medical literature analysis and retrieval system online

CENTRAL

Cochrane central register of controlled trials

CINAHL

Cumulative index to nursing and allied health literature

PEDro

Physiotherapy evidence database

Author contributions

Study concept and design: V.C., M.d.C. and M.M. Acquisition, analysis, or interpretation of data: J.G., M.H., L.G. and M.M. Drafting of the manuscript: M.M., V.C., J.C., M.d.C. Critical revision of the manuscript for important intellectual content: all authors. All authors read and approved the final manuscript.

Funding

This research was supported by two research grants (G095221N and T004420N) from the Fund of Scientific Research (FWO).

Data availability

The datasets used during the current study are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Diabetes Atlas (11th Edition). 2025; Available from: https://diabetesatlas.org/resources/idf-diabetes-atlas-2025/ [DOI] [PubMed]
  • 2.Palazzuoli A, Iacoviello M. Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence. Heart Fail Rev. 2022. [DOI] [PMC free article] [PubMed]
  • 3.Rørth R, Jhund PS, Mogensen UM, Kristensen SL, Petrie MC, Køber L, et al. Risk of incident heart failure in patients with diabetes and asymptomatic left ventricular systolic dysfunction. Diabetes Care. 2018;41(6):1285–91. [DOI] [PubMed] [Google Scholar]
  • 4.Bassuk SS, Manson JE. Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J Appl Physiol. 2005;99(3):1193–204. [DOI] [PubMed] [Google Scholar]
  • 5.Sigal RJ, Armstrong MJ, Bacon SL, Boulé NG, Dasgupta K, Kenny GP, et al. Physical activity and diabetes. Can J Diabetes. 2018;42:S54–63. [DOI] [PubMed] [Google Scholar]
  • 6.Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255–323. [DOI] [PubMed] [Google Scholar]
  • 7.American Diabetes Association Professional Practice Committee. 3. prevention or delay of diabetes and associated comorbidities: standards of care in diabetes—2025. Diabetes Care. 2024;48(Supplement_1):S50–8. [DOI] [PMC free article] [PubMed]
  • 8.Liang Z, Zhang M, Wang C, Hao F, Yu Y, Tian S, et al. The best exercise modality and dose to reduce glycosylated hemoglobin in patients with type 2 diabetes: a systematic review with pairwise, network, and dose–response meta-analyses. Sports Med. 2024;54(10):2557–70. [DOI] [PubMed] [Google Scholar]
  • 9.Jayedi A, Emadi A, Shab-Bidar S. Dose-Dependent effect of supervised aerobic exercise on HbA1c in patients with type 2 diabetes: A Meta-analysis of randomized controlled trials. Sports Med. 2022;52(8):1919–38. [DOI] [PubMed] [Google Scholar]
  • 10.Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. 2000. [DOI] [PMC free article] [PubMed]
  • 11.Hou L, Wang Q, Pan B, Li R, Li Y, He J, et al. Exercise modalities for type 2 diabetes: a systematic review and network meta-analysis of randomized trials. Diabetes Metab Res Rev. 2023;39(1):e3591. [DOI] [PubMed] [Google Scholar]
  • 12.Jansson AK, Chan LX, Lubans DR, Duncan MJ, Plotnikoff RC. Effect of resistance training on HbA1c in adults with type 2 diabetes mellitus and the moderating effect of changes in muscular strength: a systematic review and meta-analysis. BMJ Open Diabetes Res Care. 2022;10(2):e002595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Feng J, Chen J, Chen B, Yu J, Huang H, Hu Y et al. Effects of high-intensity intermittent exercise on glucose and lipid metabolism in type 2 diabetes patients: a systematic review and meta-analysis. Front Endocrinol. 2024;15. [DOI] [PMC free article] [PubMed]
  • 14.Su W, Tao M, Ma L, Tang K, Xiong F, Dai X, et al. Dose-response relationships of resistance training in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Front Endocrinol. 2023;14:1224161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Martín-Timón I. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes. 2014;5(4):444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Thompson P, Arena R, Riebe D, Pescatello L. ACSM’s new preparticipation health screening recommendations from acsm’s guidelines for exercise testing and prescription, ninth edition. Curr Sports Med Rep. 2013;12(4):215–7. [DOI] [PubMed] [Google Scholar]
  • 17.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;n71. [DOI] [PMC free article] [PubMed]
  • 18.Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan: a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Smart NA, Waldron M, Ismail H, Giallauria F, Vigorito C, Cornelissen V, et al. Validation of a new tool for the assessment of study quality and reporting in exercise training studies: TESTEX. JBI Evid Implem. 2015;13(1):9. [DOI] [PubMed] [Google Scholar]
  • 20.Higgins JPT, Thomas J. Cochrane handbook for systematic reviews of interventions.
  • 21.DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88. [DOI] [PubMed] [Google Scholar]
  • 22.Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. American college of sports medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334–59. [DOI] [PubMed] [Google Scholar]
  • 23.Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58. [DOI] [PubMed] [Google Scholar]
  • 24.Borenstein M. How to understand and report heterogeneity in a meta-analysis: the difference between I-squared and prediction intervals. Integr Med Res. 2023;12(4):101014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ. 1997;315(7121):1533–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Borenstein M. Introduction to meta-analysis. Chichester: Wiley; 2009. [Google Scholar]
  • 27.Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, et al. Exercise and type 2 diabetes: the American college of sports medicine and the American diabetes association: joint position statement. Diabetes Care. 2010;33(12):e147–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mannucci E, Bonifazi A, Monami M. Comparison between different types of exercise training in patients with type 2 diabetes mellitus: a systematic review and network metanalysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2021;31(7):1985–92. [DOI] [PubMed] [Google Scholar]
  • 29.Pan B, Ge L, Xun Y, qin, Chen Y, jing, Gao Cyun, Han X, et al. Exercise training modalities in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis. Int J Behav Nutr Phys Act. 2018;15(1):72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Meo SD, Iossa S, Venditti P. Improvement of obesity-linked skeletal muscle insulin resistance by strength and endurance training. 2017. [DOI] [PubMed]
  • 31.Sénéchal M, Swift DL, Johannsen NM, Blair SN, Earnest CP, Lavie CJ, et al. Changes in body fat distribution and fitness are associated with changes in hemoglobin A1c after 9 months of exercise training: results from the HART-D study. Diabetes Care. 2013;36(9):2843–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Gummesson A, Nyman E, Knutsson M, Karpefors M. Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes. Diabetes Obes Metab. 2017;19(9):1295–305. [DOI] [PubMed] [Google Scholar]
  • 33.Boulé NG, Weisnagel SJ, Lakka TA, Tremblay A, Bergman RN, Rankinen T, et al. Effects of exercise training on glucose homeostasis: the HERITAGE family study. Diabetes Care. 2005;28(1):108–14. [DOI] [PubMed] [Google Scholar]
  • 34.Way KL, Hackett DA, Baker MK, Johnson NA. The effect of regular exercise on insulin sensitivity in type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab J. 2016;40(4):253–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Twist C, Bott R, Highton J. The physiological, perceptual and neuromuscular responses of team sport athletes to a running and cycling high intensity interval training session. Eur J Appl Physiol. 2023;123(1):113–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Dunstan DW, Daly RM, Owen N, Jolley D, Vulikh E, Shaw J, et al. Home-based resistance training is not sufficient to maintain improved glycemic control following supervised training in older individuals with type 2 diabetes. Diabetes Care. 2005;28(1):3–9. [DOI] [PubMed] [Google Scholar]
  • 37.Ishiguro H, Kodama S, Horikawa C, Fujihara K, Hirose AS, Hirasawa R, et al. In search of the ideal resistance training program to improve glycemic control and its indication for patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Sports Med. 2016;46(1):67–77. [DOI] [PubMed] [Google Scholar]
  • 38.Imran HM, Baig M, Erqou S, Taveira TH, Shah NR, Morrison A, et al. Home-based cardiac rehabilitation alone and hybrid with center‐based cardiac rehabilitation in heart failure: a systematic review and meta‐analysis. J Am Heart Assoc. 2019;8(16):e012779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Kokkinos P, Myers J, Nylen E, Panagiotakos DB, Manolis A, Pittaras A, et al. Exercise capacity and All-Cause mortality in African American and Caucasian men with type 2 diabetes. Diabetes Care. 2009;32(4):623–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Wang M, Collings PJ, Jang H, Chen Z, Shi Q, Ho HS, et al. Prospective associations between muscle strength and genetic susceptibility to type 2 diabetes with incident type 2 diabetes: a UK biobank study. BMC Med. 2025;23(1):93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Wei L, Zeng J, Fan M, Chen B, Li X, Li Y, et al. Associations between handgrip strength and skeletal muscle mass with all-cause mortality and cardiovascular mortality in people with type 2 diabetes: a prospective cohort study of the UK biobank. J Diabetes. 2023;16(1):e13464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Zhao T, Yang Q, Feuerbacher JF, Yu B, Brinkmann C, Cheng S et al. Effects of exercise, metformin and their combination on glucose metabolism in individuals with abnormal glycaemic control: a systematic review and network meta-analysis. 2024. [DOI] [PubMed]
  • 43.MacDonald CS, Johansen MY, Nielsen SM, Christensen R, Hansen KB, Langberg H, et al. Dose-Response effects of exercise on Glucose-Lowering medications for type 2 diabetes: a secondary analysis of a randomized clinical trial. Mayo Clin Proc. 2020;95(3):488–503. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material 1 (4.1MB, docx)

Data Availability Statement

The datasets used during the current study are available from the corresponding author on reasonable request.


Articles from Cardiovascular Diabetology are provided here courtesy of BMC

RESOURCES